Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine

por McAllister, Peter, Kudrow, David, Cady, Roger, Hirman, Joe, Ettrup, Anders
Publicado 2022

Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy

por Mullin, Kathleen, Kudrow, David, Croop, Robert, Lovegren, Meghan, Conway, Charles M., Coric, Vladimir, Lipton, Richard B.
Publicado 2020

Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor

por Kessler, John A., Shaibani, Aziz, Sang, Christine N., Christiansen, Mark, Kudrow, David, Vinik, Aaron, Shin, Nari
Publicado 2021

A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine

por Camporeale, Angelo, Kudrow, David, Sides, Ryan, Wang, Shufang, Van Dycke, Annelies, Selzler, Katherine J., Stauffer, Virginia L.
Publicado 2018

Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial

por Kudrow, David, Cady, Roger K., Allan, Brent, Pederson, Susan M., Hirman, Joe, Mehta, Lahar R., Schaeffler, Barbara A.
Publicado 2021

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan

por Kudrow, David, Krege, John H., Hundemer, Hans P., Berg, Paul H., Khanna, Rashna, Ossipov, Michael H., Pozo‐Rosich, Patricia
Publicado 2020

A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or rec...

por Kudrow, David, Nguyen, Linda, Semler, Jack, Stroud, Chad, Samaan, Karen, Hoban, Deirdre B., Wietecha, Linda, Hsu, Hai‐An, Pearlman, Eric
Publicado 2022

Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine

por Spierings, Egilius LH, Brandes, Jan Lewis, Kudrow, David B, Weintraub, James, Schmidt, Peter C, Kellerman, Donald J, Tepper, Stewart J
Publicado 2017

Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)

por Brandes, Jan Lewis, Klise, Suzanne, Krege, John H, Case, Michael, Khanna, Rashna, Vasudeva, Raghavendra, Raskin, Joel, Pearlman, Eric M, Kudrow, David
Publicado 2019

Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies

por Bangs, Mark E., Kudrow, David, Wang, Shufang, Oakes, Tina M., Terwindt, Gisela M., Magis, Delphine, Yunes-Medina, Laura, Stauffer, Virginia L.
Publicado 2020

Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies

por Bangs, Mark E., Kudrow, David, Wang, Shufang, Oakes, Tina M., Terwindt, Gisela M., Magis, Delphine, Yunes-Medina, Laura, Stauffer, Virginia L.
Publicado 2020

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine

por Berman, Gary, Croop, Robert, Kudrow, David, Halverson, Philip, Lovegren, Meghan, Thiry, Alexandra C., Conway, Charles M., Coric, Vladimir, Lipton, Richard B.
Publicado 2020

Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache

por Kudrow, David, Andrews, J. Scott, Rettiganti, Mallikarjuna, Oakes, Tina, Bardos, Jennifer, Gaul, Charly, Riesenberg, Robert, Wenzel, Richard, Kuruppu, Dulanji, Martinez, James
Publicado 2020

Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache

por Andrews, J Scott, Kudrow, David, Rettiganti, Mallikarjuna, Oakes, Tina, Bardos, Jennifer N, Wenzel, Richard, Kuruppu, Dulanji K, Gaul, Charly, Martinez, James M
Publicado 2021

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-control...

por Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Publicado 2021

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, pla...

por Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Publicado 2022

Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double‐Blind, Sham‐Controlled ACT1 Study

por Silberstein, Stephen D., Mechtler, Laszlo L., Kudrow, David B., Calhoun, Anne H., McClure, Candace, Saper, Joel R., Liebler, Eric J., Rubenstein Engel, Emily, Tepper, Stewart J.
Publicado 2016

Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, o...

por Lipton, Richard B, Tepper, Stewart J, Silberstein, Stephen D, Kudrow, David, Ashina, Messoud, Reuter, Uwe, Dodick, David W, Zhang, Feng, Rippon, Gregory A, Cheng, Sunfa, Mikol, Daniel D
Publicado 2020

Early onset of efficacy with erenumab in patients with episodic and chronic migraine

por Schwedt, Todd, Reuter, Uwe, Tepper, Stewart, Ashina, Messoud, Kudrow, David, Broessner, Gregor, Boudreau, Guy P., McAllister, Peter, Vu, Thuy, Zhang, Feng, Cheng, Sunfa, Picard, Hernan, Wen, Shihua, Kahn, Joseph, Klatt, Jan, Mikol, Daniel
Publicado 2018

Vascular safety of erenumab for migraine prevention

por Kudrow, David, Pascual, Julio, Winner, Paul K., Dodick, David W., Tepper, Stewart J., Reuter, Uwe, Hong, Frank, Klatt, Jan, Zhang, Feng, Cheng, Sunfa, Picard, Hernan, Eisele, Osa, Wang, Julie, Latham, Jonathan N., Mikol, Daniel D.
Publicado 2020